John Kaldor
Profile
Professor John Kaldor is an NHMRC Senior Principal Research Fellow and Professor at the Kirby Institute, University of New South Wales.
Professor Kaldor is a member of the APPRISE Executive.
For over 25 years he has built and led internationally recognised research programs on the epidemiology and prevention of infectious diseases, with a particular focus on HIV, other bloodborne and sexually transmitted infections, and more recently, neglected tropical diseases including trachoma. His work has included the development and implementation of public health surveillance systems, investigations of risk factors for infectious disease transmission, and evaluations of public health intervention strategies.
With 600 peer-reviewed scientific publications that have been cited collectively over 20,000 times, Professor Kaldor has been a highly influential contributor to public health knowledge and policy. He has served on numerous policy and advisory committees in Australia and internationally, and has had close collaborative relationships with public health researchers in a number of countries of the Asia–Pacific region.
Related Projects
Related Publications
- Learning from COVID-19: strengthening Australia’s research capacity through preparedness and collaboration
- Serological testing of blood donors to characterise the impact of COVID-19 in Melbourne, Australia, 2020
- Experiences of risk in Australian hotel quarantine: a qualitative study
- Contact tracing indicators for COVID-19: Rapid scoping review and conceptual framework
- Effectiveness evaluation of digital contact tracing for COVID-19 in New South Wales, Australia
- Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-specific antibodies in Australia after the first epidemic wave in 2020: A national survey
- Uncertainty and agency in COVID-19 hotel quarantine in Australia
- Whole of population-based cohort study of recovery time from COVID-19 in New South Wales Australia
- Hospital outcomes after a COVID-19 diagnosis from January to May 2020 in New South Wales Australia
- Outcomes for patients with COVID‐19 admitted to Australian intensive care units during the first four months of the pandemic
- Maintaining strong foundations and building resilience: planning Australia’s path through the COVID-19 pandemic
- Seroprevalence of SARS-CoV-2-specific antibodies in Sydney, Australia following the first epidemic wave in 2020
- Influenza vaccination coverage in a population-based cohort of Australian-born Aboriginal and non-Indigenous older adults
- Towards effective outbreak detection: a qualitative study to identify factors affecting nurses’ early warning surveillance practice in Solomon Islands